Extended-spectrum β-lactamase-producing Enterobacteriaceae in Bulgarian hospitals

被引:26
|
作者
Markovska, Rumyana [2 ]
Schneider, Ines [1 ]
Keuleyan, Emma [3 ]
Sredkova, Mariya [4 ]
Ivanova, Dobrinka [5 ]
Markova, Boyka [6 ]
Lazarova, Grozdanka [7 ]
Dragijeva, Elisaveta [8 ]
Savov, Encho [9 ]
Haydouchka, Irina [10 ]
Hadjieva, Nasya [5 ]
Setchanova, Lena [2 ]
Mitov, Ivan [2 ]
Bauernfeind, Adolf [1 ]
机构
[1] MICOER Inst, D-80802 Munich, Germany
[2] Med Univ Sofia, Chair Microbiol, Sofia, Bulgaria
[3] Minist Interior, Inst Med, Sofia, Bulgaria
[4] Pleven Univ Hosp, Pleven, Bulgaria
[5] Queen Joanna Univ Hosp, Sofia, Bulgaria
[6] Alexandrovska Univ Hosp, Sofia, Bulgaria
[7] Thracian Univ Hosp, Stara Zagora, Bulgaria
[8] Pediatr Univ Hosp, Sofia, Bulgaria
[9] Mil Med Acad, Sofia, Bulgaria
[10] Plovdiv Univ Hosp, Plovdiv, Bulgaria
关键词
D O I
10.1089/mdr.2008.0814
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of the study was to describe the emergence, the spread, and the prevalence of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in Bulgaria. Over eight years (1996-2003), 442 ESBL-.screen-positive isolates were collected in nine medical institutions in four Bulgarian towns. Class A ESBLs of the SHV, TEM, and CTX-M groups were identified in seven species. SHV-type enzymes persisted during the whole study period, TEM-ESBLs appeared first in 1999, and CTX-M-types appeared first in 2001. The rate of CTX-M enzyme producers increased rapidly between 2001 and 2003, while the rate of SHV producers decreased. Six different ESBL-types were identified, namely, SHV-2,-5, and -12, CTX-M-3 and -15, and a new TEM-3-like variant (TEM-139). The most widespread enzymes were SHV-12, CTX-M-15, and CTX-M-3 found in seven centers. TEM-139 was identified mainly in one center. A trend for strains harboring more than one ESBL gene, for example, CTX-M + SHV, was observed since 2002. Plasmid fingerprinting and random amplified polymorphic DNA analysis typing revealed wide dissemination of identical plasmids among different bacterial species and hospitals, as well as clonal spread of ESBL producers. Our data contribute to clarify the dynamics in the prevalence of ESBLs in Bulgaria and demonstrate the importance of molecular procedures for their analysis.
引用
下载
收藏
页码:119 / 128
页数:10
相关论文
共 50 条
  • [41] Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae
    Bachtarzi, Raphaele
    Boureau, Anne Sophie
    Mascart, Charlotte
    Batard, Eric
    Montassier, Emmanuel
    Bemer, Pascale
    Bourigault, Celine
    Berrut, Gilles
    de Decker, Laure
    Chapelet, Guillaume
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 1763 - 1769
  • [42] Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon
    Carine Magoué Lonchel
    Cécile Meex
    Joseph Gangoué-Piéboji
    Raphaël Boreux
    Marie-Claire Okomo Assoumou
    Pierrette Melin
    Patrick De Mol
    BMC Infectious Diseases, 12
  • [43] Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options
    Gisele Peirano
    Johann D. D. Pitout
    Drugs, 2019, 79 : 1529 - 1541
  • [44] Optimizing therapy of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae
    Gudiol, Carlota
    Cuervo, Guillermo
    Carratala, Jordi
    CURRENT OPINION IN CRITICAL CARE, 2019, 25 (05) : 438 - 448
  • [45] Inventory of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study
    Robin, F.
    Beyrouthy, R.
    Bonacorsi, S.
    Aissa, N.
    Bret, L.
    Brieu, N.
    Cattoir, V.
    Chapuis, A.
    Chardon, H.
    Degand, N.
    Doucet-Populaire, F.
    Dubois, V.
    Fortineau, N.
    Grillon, A.
    Lanotte, P.
    Leyssene, D.
    Patry, I.
    Podglajen, I.
    Recule, C.
    Ros, A.
    Colomb-Cotinat, M.
    Ponties, V.
    Ploy, M. C.
    Bonnet, R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (03)
  • [46] A novel framework to compare the effectiveness of β-lactamase inhibitors against extended-spectrum β-lactamase-producing Enterobacteriaceae
    Abodakpi, H.
    Chang, K. T.
    Zhou, J.
    Byerly, C.
    Tam, V. H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (09) : 1154.e9 - 1154.e14
  • [47] Frequency of extended-spectrum β-lactamase (ESBL)- and AmpC β-lactamase-producing Enterobacteriaceae in a cheese production process
    Tepeli, Seda Ozdikmenli
    Zorba, Nukhet N. Demirel
    JOURNAL OF DAIRY SCIENCE, 2018, 101 (04) : 2906 - 2914
  • [48] Extended-spectrum β-lactamase-producing Escherichia coli
    Huang, Ying
    Zeng, Li
    Doi, Yohei
    Lv, Luchao
    Liu, Jian-Hua
    LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 404 - 405
  • [49] High prevalence and characterization of extended-spectrum ß-lactamase producing Enterobacteriaceae in Chadian hospitals
    Mahamat, Oumar Ouchar
    Lounnas, Manon
    Hide, Mallorie
    Dumont, Yann
    Tidjani, Abelsalam
    Kamougam, Kadidja
    Abderrahmane, Madina
    Benavides, Julio
    Solassol, Jerome
    Banuls, Anne-Laure
    Jean-Pierre, Helene
    Carriere, Christian
    Godreuil, Sylvain
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [50] High prevalence and characterization of extended-spectrum ß-lactamase producing Enterobacteriaceae in Chadian hospitals
    Oumar Ouchar Mahamat
    Manon Lounnas
    Mallorie Hide
    Yann Dumont
    Abelsalam Tidjani
    Kadidja Kamougam
    Madina Abderrahmane
    Julio Benavides
    Jérôme Solassol
    Anne-Laure Bañuls
    Hélène jean-Pierre
    Christian Carrière
    Sylvain Godreuil
    BMC Infectious Diseases, 19